From medicine to business and wellness
A new blood test that can detect circulating tumor DNA (ctDNA) could potentially save thousands of cancer patients from unnecessary annual chemotherapy. Currently, the gold standard treatment for many cancer patients is intravenous chemotherapy, which can cause long-term nerve damage and painful side effects.
Subscribe to get the latest posts sent to your email.
Prof. Roger D. Kornberg, the Nobel Prize-winning chemist from Stanford University, is poised to join Rehovot-based Tissue Dynamics’ advisory board,…
Three New Subtypes of Brain Cancer Were Identified at RCSI University of Medicine and Health Sciences in Dublin. They are…
France’s healthcare system is facing a crisis despite having more doctors and nurses per capita than the UK. The pressure…